Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Celecoxib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Celecoxib 100mg capsules
1001010AHAAAAAA
|
Celecoxib | Celecoxib | Musculoskeletal and Joint Diseases | 52,207 |
|
Celecoxib 200mg capsules
1001010AHAAABAB
|
Celecoxib | Celecoxib | Musculoskeletal and Joint Diseases | 38,041 |
|
Celebrex 100mg capsules
1001010AHBBAAAA
|
Celebrex | Celecoxib | Musculoskeletal and Joint Diseases | 927 |
|
Celebrex 200mg capsules
1001010AHBBABAB
|
Celebrex | Celecoxib | Musculoskeletal and Joint Diseases | 766 |
|
Celecoxib 400mg capsules
1001010AHAAADAD
|
Celecoxib | Celecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Celecoxib 50mg/5ml oral suspension
1001010AHAAAEAE
|
Celecoxib | Celecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Onsenal 400mg capsules
1001010AHBCAAAD
|
Onsenal | Celecoxib | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.